pillbase.ru

Ninlaro

Active substance: ixazomib

ixazomib citrate

Centralised EU authorisationActive

Marketing holder: Takeda Pharma A/S

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • NINLARO
    CAPSULE · IXAZOMIB CITRATE 4 mg/1
    63020-400
    Takeda Pharmaceuticals America, Inc.
  • NINLARO
    CAPSULE · IXAZOMIB CITRATE 2.3 mg/1
    63020-230
    Takeda Pharmaceuticals America, Inc.
  • NINLARO
    CAPSULE · IXAZOMIB CITRATE 3 mg/1
    63020-390
    Takeda Pharmaceuticals America, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-63c5-7ebf-b53d-073426c6fc91,01a12096-ae47-7c46-9696-7808069fc206,01a1209d-c050-7a54-a328-64732efa3f9b;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/003844
Registration status
Active
ATC code
L01XG03
Sources
  • product · EMA · EMEA/H/C/003844 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/003844 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/003844 · Verified 2026-10-09